An example from non-traumatic emergency patient group in a post-conflict low-income region: Dialysis patients applying to the emergency department in northwest Syria
Post-conflict area emergency patients of dialysis
Keywords:emergency department, hemodialysis, post-conflict area, Syria
In this study, we aimed to investigate the demographic characteristics, comorbidities and reasons for applying to emergency dialysis in Syrian hemodialysis patients who applied to the emergency department.
This study was conducted at AAA Hospital and BBB Hospitals in northwestern Syria. This study included end-stage renal failure (ESRD) patients and underwent emergency hemodialysis as a result of emergency department visits between January 1, 2022, and March 31, 2022. Demographic data, vital signs, laboratory results, concomitant diseases, and indications for emergency dialysis were investigated retrospectively and analyzed statistically.
In this study has been detected that the mean age of the participants was 58 years and 34 (59.6%) of the patients were male and 23 (40.4%) were female. The patients who received two dialysis sessions per week older the patients who received three dialysis sessions per week (p=0.030). The presence of hypertension was found to be significantly higher in patients who received three sessions per week (p=0.004). Emergency dialysis was performed in 26.3% of patients due to hypervolemia, in 14.1% due to hyperkalemia, in 29.8% due to uremic findings, and in 29.8% due to metabolic acidosis. When the laboratory parameters have been investigated only sodium values were found to be significantly higher in patients who received two sessions of hemodialysis (p=0.004).
It may suggest that further increasing the hemodialysis service in northwest Syria may contribute to reaching the peak benefit to decrease the emergency dialysis patients.
How to Cite
Copyright (c) 2022 International Journal of Current Medical and Biological Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.